Status: current, Defined. Date: 31-Mar 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3171651000168115 | Praluent (alirocumab 75 mg / 1 mL) injection, 2 x 1 mL pen devices (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3171661000168118 | Praluent 75 mg/mL injection, 2 x 1 mL pen devices | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Praluent 75 mg/mL injection, 2 x 1 mL pen devices | Is a | trade product pack | true | Inferred relationship | Some | ||
| Praluent 75 mg/mL injection, 2 x 1 mL pen devices | Is a | alirocumab 75 mg/mL injection, 2 x 1 mL pen devices | true | Inferred relationship | Some | ||
| Praluent 75 mg/mL injection, 2 x 1 mL pen devices | has TPUU | Praluent 75 mg/mL injection, pen device | true | Inferred relationship | Some | 1 | |
| Praluent 75 mg/mL injection, 2 x 1 mL pen devices | has TP | Praluent | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Praluent 75 mg/mL injection, 2 x 1 mL pen devices | Is a | True | Praluent 75 mg/mL injection, 2 x 1 mL pen devices | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR